Xtrackers FTSE Developed ex US Multifactor ETF (DEEF)
Live price chart, market sentiment, and community perspectives for Xtrackers FTSE Developed ex US Multifactor ETF (AMEX: DEEF).
Live price chart, market sentiment, and community perspectives for Xtrackers FTSE Developed ex US Multifactor ETF (AMEX: DEEF).
Looking at the quantitative risk profile for DEEF, the 5-year Sharpe ratio of 0.32 visibly lags the Foreign Large Value category median of 0.54. Even with a lower beta of 0.74, the risk-adjusted returns don't quite justify the lower structural efficiency over extended multi-year horizons.
When analyzing the execution protocols for this multifactor ETF, note that short interest has dropped precipitously down to effectively zero (33 shares as of April), indicating a complete absence of active short-side positioning or squeeze catalysts in the near term.
From our market sentiment tracking desk, DEEF enjoys a predominantly positive narrative across social media and financial aggregators. However, with a smaller market cap hovering around $54M to $57M and very light trading volumes averaging just over 1,000 shares daily, liquidity requires careful handling.
Our risk management assessment highlights that DEEF's 5-year maximum drawdown reached -28.4%, underperforming the category average of -24.6%. The fund also exhibited a 5-year downside capture of 95, absorbing more benchmark downward pressure than its peers despite matching an upside capture of 92.
Watching the recent price action around the $39 to $40 range, DEEF functions best as an unhedged satellite allocation for long-term buy-and-hold portfolios seeking international factor exposure, provided investors can tolerate periodic return shortfalls against broader category benchmarks.
Explore plasma cleansing, somatic organ swaps, and BCI.